Journal of Diabetes and Its Complications
Volume 23, Issue 2 , Pages 102-111 , March 2009

Oxidative stress pathway genes and chronic renal insufficiency in Asian Indians with Type 2 diabetes

  • Arun K. Tiwari

      Affiliations

    • Department of Genetics, University of Delhi South Campus, New Delhi 110 021, India
    • ,
  • Pushplata Prasad

      Affiliations

    • Department of Genetics, University of Delhi South Campus, New Delhi 110 021, India
    • ,
  • Thelma B.K.

      Affiliations

    • Department of Genetics, University of Delhi South Campus, New Delhi 110 021, India
    • Corresponding Author InformationCorresponding author. Tel.: +91 11 24118201; fax: +91 11 24112761.
    • ,
  • K.M. Prasanna Kumar

      Affiliations

    • Department of Endocrinology and Metabolism, M.S. Ramiah Medical College, Bangalore, India
    • ,
  • A.C. Ammini

      Affiliations

    • Department of Endocrinology, All India Institute of Medical Sciences, New Delhi, India
    • ,
  • Arvind Gupta

      Affiliations

    • Jaipur Diabetes Research Centre, Jaipur, India
    • ,
  • Rajeev Gupta

      Affiliations

    • Monilek Hospital and Research Centre, Jaipur, India

Received 18 April 2007 ,Revised 16 July 2007 ,Accepted 18 October 2007.

References 

  1. American Diabetes Association . Diabetic nephropathy. Diabetes Care. 2002;25:S85–S89
  2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813–820
  3. Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes. 2005;54:1615–1625
  4. Basu A, Mukherjee N, Roy S, Sengupta S, Banerjee S, Chakraborty M, et al. Ethnic India: A genomic view, with special reference to peopling and structure. Genome Research. 2003;13:2277–2290
  5. Chistyakov DA, Savost'anov KV, Zotova EV, Nosikov VV. Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus. BMC Medical Genetics. 2001;2:4
  6. Czekalski S. Diabetic nephropathy and cardiovascular diseases. Roczniki Akademii Medycznej w Bialymstoku. 2005;50:122–125
  7. Doney AS, Lee S, Leese GP, Morris AD, Palmer CN. Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: A Go-DARTS study. Circulation. 2005;111:2927–2934
  8. Earle KK, Porter KA, Ostberg J, Yudkin JS. Variation in the progression of diabetic nephropathy according to racial origin. Nephrology, Dialysis, Transplantation. 2001;16:286–290
  9. Esterbauer H, Schneitler C, Oberkofler H, Ebenbichler C, Paulweber B, Sandhofer F, et al. A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nature Genetics. 2001;28:178–183
  10. Fujita H, Narita T, Meguro H, Ishii T, Hanyu O, Suzuki K, et al. Lack of association between an ecNOS gene polymorphism and diabetic nephropathy in type 2 diabetic patients with proliferative diabetic retinopathy. Hormone and Metabolic Research. 2000;32:80–83
  11. Fujita H, Narita T, Meguro H, Shimotomai T, Kitazato H, Kagaya E, et al. No association of glutathione S-transferase M1 gene polymorphism with diabetic nephropathy in Japanese type 2 diabetic patients. Renal Failure. 2000;22:479–486
  12. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New England Journal of Medicine. 2004;351:1296–1305
  13. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: Diagnosis, prevention, and treatment. Diabetes Care. 2005;28:164–176
  14. Gupta R, Misra A. Type-2 diabetes epidemiology in India: Focus on regional disparities. British Journal of Diabetes Vascular Diseases. 2007;7:12–16
  15. Hayden MR, Whaley-Connell A, Sowers JR. Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: Paying homage to the podocyte. American Journal of Nephrology. 2005;25:553–569
  16. Herrmann SM, Wang JG, Staessen JA, Kertmen E, Schmidt-Petersen K, Zidek W, et al. Uncoupling protein 1 and 3 polymorphisms are associated with waist-to-hip ratio. International Journal of Molecular Medicine. 2003;81:327–332
  17. Hu X, Xia H, Srivastava SK, Pal A, Awasthi YC, Zimniak P, et al. Catalytic efficiencies of allelic variants of human glutathione S-transferase P1-1 toward carcinogenic anti-diol epoxides of enzo[c]phenanthrene and benzo[g]chrysene. Cancer Research. 1998;58:5340–5343
  18. King GL, Loeken MR. Hyperglycemia-induced oxidative stress in diabetic complications. Histochemistry and Cell Biology. 2004;122:333–338
  19. Ksiazek P, Wojewoda P, Muc K, Buraczynska M. Endothelial nitric oxide synthase gene intron 4 polymorphism in type 2 diabetes mellitus. Molecular Diagnosis. 2003;7:119–123
  20. Leon CA, Raij L. Interaction of haemodynamic and metabolic pathways in the genesis of diabetic nephropathy. Journal of Hypertension. 2005;23:1931–1937
  21. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Annals of Internal Medicine. 2003;139:137–147
  22. Lin CC, Wu HC, Tsai FJ, Chen HY, Chen WC. Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer. Urology. 2003;62:374–377
  23. Mann JF. Cardiovascular risk in patients with mild renal insufficiency: Implications for the use of ACE inhibitors. La Presse Medicale. 2005;34:1303–1308
  24. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Annals of Internal Medicine. 2001;134:629–636
  25. Matsunaga-Irie S, Maruyama T, Yamamoto Y, Motohashi Y, Hirose H, Shimada A, et al. Relation between development of nephropathy and the p22pHOX C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients. Diabetes Care. 2004;27:303–307
  26. Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M, et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension. 1998;32:3–8
  27. Mohan V. Indians more prone to diabetes?. Journal of the Association of Physicians of India. 2004;52:468–474
  28. Mori H, Okazawa H, Iwamoto K, Maeda E, Hashiramoto M, Kasuga M. A polymorphism in the 5′ untranslated region and a Met229−>Leu variant in exon 5 of the human UCP1 gene are associated with susceptibility to type II diabetes mellitus. Diabetologia. 2001;44:373–376
  29. Nagai N, Sakane N, Ueno LM, Hamada T, Moritani T. The −3826 A−>G variant of the uncoupling protein-1 gene diminishes postprandial thermogenesis after a high fat meal in healthy boys. Journal of Clinical Endocrinology and Metabolism. 2003;88:5661–5667
  30. Neugebauer S, Baba T, Watanabe T. Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes. 2000;49:500–503
  31. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404:787–790
  32. Nomiyama T, Tanaka Y, Piao L, Nagasaka K, Sakai K, Ogihara T, et al. The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. Journal of Human Genetics. 2003;48:138–141
  33. Pinizzotto M, Castillo E, Fiaux M, Temler E, Gaillard RC, Ruiz J. Paraoxonase2 polymorphisms are associated with nephropathy in Type II diabetes. Diabetologia. 2001;44:104–107
  34. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. Journal of Vascular Research. 2000;37:443–448
  35. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR. Risk factors for renal dysfunction in type 2 diabetes: UK. Prospective diabetes study 74. Diabetes. 2006;55:1832–1839
  36. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. New England Journal of Medicine. 1999;341:1127–1133
  37. Ritz E, Stefanski A. Diabetic nephropathy in type II diabetes. American Journal of Kidney Diseases. 1996;27:167–194
  38. Rosenblum JS, Gilula NB, Lerner RA. On signal sequence polymorphisms and diseases of distribution. Proceedings of the National Academy of Sciences of the United States of America. 1996;93:4471–4473
  39. Ruggenenti P, Remuzzi G. Nephropathy of type-2 diabetes mellitus. Journal of the American Society of Nephrology. 1998;9:2157–2169
  40. Salanti G, Amountza G, Ntzani EE, Ioannidis JP. Hardy–Weinberg equilibrium in genetic association studies: An empirical evaluation of reporting, deviations, and power. European Journal of Human Genetics. 2005;13:840–848
  41. Santos KG, Canani LH, Gross JL, Tschiedel B, Souto KE, Roisenberg I. Relationship of p22pHOX C242T polymorphism with nephropathy in type 2 diabetic patients. Journal of Nephrology. 2005;18:733–738
  42. Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Annals of Human Genetics. 1995;59:97–105
  43. Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. Journal of the American Medical Association. 2002;288:2579–2588
  44. Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. Journal of the American College of Cardiology. 1998;31:1506–1510
  45. Shimizu T, Onuma T, Kawamori R, Makita Y, Tomino Y. Endothelial nitric oxide synthase gene and the development of diabetic nephropathy. Diabetes Research and Clinical Practice. 2002;58:179–185
  46. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. Biochemical and Biophysical Research Communications. 1996;226:561–565
  47. Stephens M, Donnelly P. Comparison of Bayesian methods for haplotype reconstruction from population genotype data. American Journal of Human Genetics. 2003;73:1162–1169
  48. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. American Journal of Human Genetics. 2001;68:978–989
  49. van Dijk C, Berl T. Pathogenesis of diabetic nephropathy. Reviews in Endocrine and Metabolic Disorders. 2004;5:237–248
  50. Viswanatham V, Snehalatha C, Mathai T, Jayaraman M, Ramachandran A. Cardiovascular morbidity in proteinuric south Indian NIDDM patients. Diabetes Research and Clinical Practice. 1998;39:63–67
  51. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053
  52. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Human Genetics. 1998;103:65–69
  53. Young BA, Maynard C, Boyko EJ. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care. 2003;26:2392–2399

☆ This study received financial assistance through senior research fellowships to Arun K. Tiwari, from University Grants Commission, New Delhi, and Pushplata Prasad, from Council of Scientific and Industrial Research, New Delhi, India.

PII: S1056-8727(07)00131-6

doi: 10.1016/j.jdiacomp.2007.10.003

Journal of Diabetes and Its Complications
Volume 23, Issue 2 , Pages 102-111 , March 2009

Article Tools